Sebastien Beauzile just rewrote the future for New York. At 21, he became the first person in the state cured of sickle cell disease using Lyfgenia gene therapy. On December 17, 2024, he received the treatment. Today, he’s completely symptom-free. “This is a fix,” his doctor told the New York Post. “Other drugs modify the disease, but this is a cure.” Sebastien’s story is proof, the cure works. But access still doesn’t. The treatment costs $3.1 million, leaving thousands wait
.png)
